FDA issues BIA-ALCL update, qualifies BREAST-QAugust 24
The FDA issued an update to its breast implant safety webpages on Aug. 20 regarding adverse events reported to the Agency related to breast implants, including Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and data on medical device reports (MDR) the FDA has received on "Breast Implant Illness."
- Remembering internationally renowned plastic surgeon Ian Jackson, MD, 1934-2020 August 3
- PRS scores all-time-high Impact Factor, joins 'upper echelon' of journals July 16
- Social Media Focus: Be the star of your own reality TV show: An Instagram TV Guide July 10
- ASPS joins Surgical Care Coalition in effort to protect patients, members June 18